A recent study suggests that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt conventional lifestyle programs.
Findings released in a major health publication demonstrates that while obese people often shed a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"Users buying these drugs must be cognizant of the potential of fast rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
This pace of regain implies a reversion to starting weight in about 18 months.
Weighing Approaches
The research, which examined 37 of studies involving over 9,000 of patients, compared the effects of these new drugs with other pills.
Researchers note that people who lose weight through diet and exercise usually see a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Rebound
Doctors suggest the mode of action of the drugs accounts for the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 levels far above than normal might result in the system to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating much more probable."
A Chronic Disease?
The NHS recommend the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, considering the likelihood of weight regain, the therapy should be considered long-term.
This perspective is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
People who have come off the medication explain a sudden resurgence of cravings.
"It felt as if a trigger flipping and I was suddenly extremely hungry," described one woman.
The struggle is worsened if users have not established permanent lifestyle or habit changes during therapy.
Growing Use
Survey data suggest that millions of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is more common among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
Ultimately, experts stress that while these medications are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing behavioural management.
